Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor-Positive, ERBB2-Negative Advanced Breast Cancer: A Randomized Clinical Trial - Llombart-Cussac, A; Perez-Garcia, JM; Bellet, M (JAMA Oncol, 2021)